M

Merge Labs

Develops high-bandwidth brain–computer interfaces

Scientist – Ultrasound-Mediated Gene Delivery

Translational Research & Bench BiologyConfirmed live in the last 24 hours
Full-timeSan Francisco, CA, USA$120k - $215k /yrIn-person

About the Job

Requirements

  • Prior hands-on experience using focused ultrasound to deliver genes to the brain in preclinical models.
  • Demonstrated expertise in developing or optimizing gene delivery modalities.
  • Experience developing and using methods to evaluate gene delivery and expression in brain tissues.
  • Experience optimizing focused ultrasound parameters to achieve specific expression goals.
  • A Ph.D. or equivalent experience leading research projects end-to-end in bioengineering, neuroscience, cell biology, molecular biology, or a related field.

Responsibilities

  • Develop preclinical gene delivery approaches using focused ultrasound paired with viral and non-viral delivery technologies.
  • Systematically optimize focused ultrasound parameters against each delivery vehicle to maximize expression, spatial precision, and safety.
  • Collaborate with teams building the assays and readouts needed to quantify delivery, expression, and tolerability in brain tissue.
  • Design, run, and interpret in vivo experiments, iterating rapidly from data to the next round of optimization.
  • Evaluate emerging delivery technologies and help shape the team's longer-term delivery strategy.

Desired Qualifications

  • Expertise in non-viral delivery modalities.
  • Experience sourcing, evaluating, or in-licensing delivery technologies through external collaboration.
  • Experience working with large animal models.

About the Company

Merge Labs

Develops high-bandwidth brain–computer interfaces

Merge Labs develops brain–computer interfaces to connect human brains with computers. Its product focus is high-bandwidth neural implants that read neural signals and transmit data to AI systems and software, enabling bidirectional communication between brain and machine. The implants are designed to work with advances in AI and neural sensing hardware, using a system of implants, interfaces, and software to interpret brain activity and control devices or software. Compared with competitors, Merge Labs aligns with Sam Altman’s vision of human–machine convergence, leveraging OpenAI ventures connections and positioning itself as a Neuralink rival with an emphasis on higher data throughput and scalable AI-assisted interpretation. The company’s goal is to create seamless, high-bandwidth brain–computer communication that enhances human capabilities and enables new ways of interacting with technology.

Company size
51-200
Company stage
Seed
Total funding
$252M
Headquarters
San Francisco, CA
Founded
2025

Recently Posted Jobs

Explore more opportunities at Merge Labs

See more jobs